Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the study (2023-2024), comprised of ...
Morning Overview on MSN
The FDA just approved Auvelity for Alzheimer-related agitation — the first non-antipsychotic ever cleared for the hardest behavioral symptom families have to man…
Families caring for someone with Alzheimer’s disease now have a second FDA-cleared drug for agitation, and for the first time ...
Modern medicine has greatly improved the ability to treat disease, reduce pain, and prolong life. However, taking too many ...
A few weeks ago I wrote about hip fractures in the elderly. I did not disclose at the time I had someone specific in mind: my ...
Uncover the challenges of deprescribing medications in older adults and the need for clear communication and multidisciplinary care.
To address the growing problem of overprescribing for seniors, a new Canadian guideline is calling for routine medication ...
Objectives Despite adherence to guideline-based pharmacotherapy, many people with diabetic kidney disease (DKD) were unable to meet glycaemic and blood pressure targets. The purpose of this paper was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results